- Supported exchanges /
- NASDAQ /
- ENGNW.NASDAQ
enGene Holdings Inc. Warrants (ENGNW NASDAQ) stock market data APIs
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
enGene Holdings Inc. Warrants Financial Data Overview
1.5 | |
1.5 | |
- | |
1.5 | |
1.5 | |
0.391-6.5 | |
0 | |
0 | |
0 | |
-0.683 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
enGene Holdings Inc. Warrants Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -54 995 000
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get enGene Holdings Inc. Warrants Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get enGene Holdings Inc. Warrants End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: